Clinical Trial Update: Amlodipine Plus Botulinum Toxin for Focal Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the combination of amlodipine and botulinum toxin for focal dystonia has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Dystonia

Drugs mentioned

• Amlodipine (amlodipine)
• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Focal Dystonia | Phase 2 | Status: COMPLETED | Results posted: 2013-04-01